ProBiotix Health
Contact
  • Home
  • About Us
    • About Us
    • History
    • ProBiotix Products
    • Group Strategy 
  • Financials
    • Latest Results
    • Annual & Interim Reports
    • Financial Calendar
  • Corporate
    • Aquis Rules
    • Company Information
    • The Board
    • Corporate Governance
    • Advisors
    • Admission Document
  • Share Information
    • Share Price
    • Shareholder Information
  • RNS and Alerts
    • RNS & Investor News
    • Investor Alert

RNS Announcements

2023

04 January
Commercial and scientific update

2022

28 September
Unaudited Results to 30 June 2022
14 September
New commercialisation partner in Asia Pacific
14 June
Appointment of Chief Executive Officer
31 May
Launch of cholesterol reducing yoghurt
19 April
Change of registered office
01 April
Holding(s) in Company
31 March
Admission to trading on AQSE and first day of dealings

Latest RNS News

04 January 2023

Commercial and scientific update

28 September 2022

Unaudited Results to 30 June 2022

14 September 2022

New commercialisation partner in Asia Pacific

Latest Interview

ProBiotix Health anticipating "big commercial opportunities" during 2023
Group CEO Stephen O’Hara and CEO Steen Anderson | 04 January 2023
www.proactiveinvestors.co.uk

link...

Investor Alert

ProBiotix Health ProBiotix-Health-logo

Copyright © . All rights reserved.

  • Investor Communications Privacy Policy
  • Sitemap